"Fax: (763) 302-4345"

During the past decade, Minneapolis Clinic of Neurology conducted 16 clinical trials. In the 10-year time frame, 16 clinical trials started and 18 clinical trials were completed, i.e. on average, 112.5% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 8 clinical trials were completed. i.e. 400% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Minneapolis Clinic of Neurology" #1 sponsor was "Hoffmann-La Roche" with 5 trials, followed by "Sunovion" with 4 trials sponsored, "Genentech, Inc." with 3 trials sponsored, "Allergan" with 2 trials sponsored and "Celgene" with 2 trials sponsored. Other sponsors include 5 different institutions and companies that sponsored additional 13 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Minneapolis Clinic of Neurology" #1 collaborator was "Autoimmunity Centers of Excellence" with 1 trials as a collaborator, "EMD Serono" with 1 trials as a collaborator, "Novartis Pharmaceuticals" with 1 trials as a collaborator and "Pfizer" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Minneapolis Clinic of Neurology" are "Epilepsy" (3 trials), "Multiple Sclerosis" (3 trials), "Multiple Sclerosis, Relapsing-Remitting" (3 trials), "Cardiovascular Disease" (2 trials) and "Drug Resistant Partial Onset Seizure" (2 trials). Many other conditions were trialed in "Minneapolis Clinic of Neurology" in a lesser frequency.

Most popular intervention types in "Minneapolis Clinic of Neurology" are "Drug" (24 trials), "Biological" (1 trials), "Other" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Ocrelizumab" (6 trials), "Placebo" (5 trials), "Interferon beta-1a" (3 trials), "Eslicarbazepine acetate" (2 trials) and "Interferon beta-1a-matching placebo" (2 trials). Other intervention names were less common.

The vast majority of trials in "Minneapolis Clinic of Neurology" are 26 trials for "All" genders.

Currently, there are NaN active trials in "Minneapolis Clinic of Neurology". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 17 completed trials in Minneapolis Clinic of Neurology, undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in Minneapolis Clinic of Neurology, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 19 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 0 trials that are defined as “Not Applicable".